3D Bioprinting Market Overview:
The worldwide 3D Bioprinting market volume was evaluated at 481 million US dollars in year 2014. It is predicted to observe a substantial expansion and growth. Also it will receive maximum attention from healthcare researchers during the estimated period due to growing occurrence of chronic ailments resulting in tissue and organ transplantations combined with growing life span of persons and restricted amount of donors of organs.
Modernization in techniques and inclusion of information technology within the healthcare sector, growing old age population base and enhanced research & development efforts made for the development and growth of this sector are predicted to serve the long term interests of this sector. All these factors are going to have high impact on the growth of the 3D Bioprinting market encouraging the expansion of the market. As on year 2015, many educational institutes, universities as well as research institutes have begun examining the future prospects of bio printed implants, tissue reconstructions and organs. For example, the Herriot Watt University of Scotland made a 3D bio printer capable of printing the pluripotent stem cell cultures applied for testing the medicines and drugs.
Yet another instance displaying the considerable growth of the market is the great current achievement and breakthrough in the field of thyroid gland transplantation in mice by using the 3D Bioprinting technique for treating ailment of hypothyroidism. If the outcomes are positive, the firm will begin testing the technique for using it for human beings in next few years.
3D Bioprinting Market By Technology:
Technologies used in 3D Bioprinting sector includes syringe based 3D Bioprinting, magnetic levitation, inkjet based 3D Bioprinting and laser based 3D Bioprinting. Magnetic levitation along with syringe based 3D bioprinters held the largest market share in year 2014. The laser technique is predicted to observe the rapid growth in future. Also, syringe based technique is predicted to get higher adaptation in future.
The next generation magnetic levitation 3D bio printers are predicted to resolve more than eighty percent of the recent failure problems along with improving of precision and speed. Magnetic levitation printers find its applications in human cell generation, toxicity screening, drug response management and human cell generation.
3D Bioprinting Market By Application:
Main applications examined in the study includes biosensors, dental, Bioinks, medical, food and animal product Bioprinting as well as consumer & personal item testing. The medical section is forecasted to lead the global 3D Bioprinting market with more than thirty percent of market share in year 2022. It is predicted to cover the regeneration of implants, organs, tissues and prosthetics along with producing of medical invoice.
A medical pill is the recent breakthrough in the global 3D Bioprinting market. It is predicted to observe high growth during the forecasted period. This expansion and growth can be ascribed to the growing requirement of drugs and the benefit of fast as well as cost effective manufacturing of bio drugs by using 3D Bioprinting. As per the different market experts, the pharmaceutical sector is predicted to grow manifolds thereby raising the size of medical invoice production.
3D Bioprinting Market By Region:
Sub Continent of North America is predicted to lead the global 3D Bioprinting market in terms of total income during the estimated period. It held more than 36% of the total market share in year 2014 and is predicted to grow at a CAGR growth rate of 10.3%. Presence of a large old age population as well as chronically sick population within the region combined with good healthcare infrastructure, efficient health care services, rise in per capita income and high patient disposable levels of income are the main drivers encouraging the growth of the 3D Bioprinting market in this region.
Further, intensive research & development events recently carried out within this region of North America are predicted to be important growth aspects during the estimated period.
APAC region is predicted to observe high growth due to high growth of healthcare IT sector in this region along with fast acceptance of new technologies by the key market establishments & key market player established in this region. In addition to this, growing level of consciousness among the capital investors, rise in proportion of foreign investments . Increase in number of research activities plus government support is predicted to fuel the growth of the 3D Bioprinting sector of this region in coming years.
Key market players functioning in the 3D Bioprinting market includes Cyfuse Biomedical, BioBots, Bio3D Technologies, Organovo, Envision TEC, Bio3D Technologies, Solidscape, Stratasys Limited, 3Dynamics Systems, Oceanz 3D printing & Additive Manufacturing, Voxeljet, TeVido BioDevices, Aspect Biosystems, Luxexcel Group BV, 3D Systems, CELLINK and Materialise NV.
Many of the key industry players have made collaborations and associations with various educational institutes, universities and research firms which function on organ regeneration technologies and grafting. In addition to this, these market players are arranging various kinds of seminars and exhibitions to create worldwide awareness about the applications, uses and benefits of using 3D Bioprinting technology.
Global Market Estimate and Forecast, 2012 - 2022 (USD Million)
Research Methodology, Importance and Sources
3D Bioprinting Market Industry Position
3D Bioprinting Market Application View
3D Bioprinting Market Regional View